SVRA
Savara IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$993.87M
P/E Ratio
—
EPS
$-0.53
Beta
0.31
52W High
$7.00
52W Low
$1.89
50-Day MA
$5.47
200-Day MA
$4.66
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.41
PEG Ratio
0.00
About Savara Inc
Savara Inc. is a lung disease orphan company. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | 1,000 |
| Gross Profit (TTM) | $-81.40M |
| EBITDA | $-122.68M |
| Operating Margin | 0.00% |
| Return on Equity | -63.40% |
| Return on Assets | -32.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.80 |
| Price-to-Book | 4.89 |
| Price-to-Sales (TTM) | 145272.62 |
| EV/Revenue | 4269.22 |
| EV/EBITDA | -4.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $204.92M |
| Float | $130.03M |
| % Insiders | 2.63% |
| % Institutions | 99.02% |
Historical Volatility
HV 10-Day
49.37%
HV 20-Day
50.41%
HV 30-Day
52.74%
HV 60-Day
52.51%
HV Rank
36.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($10.81 target)
2
Strong Buy6
BuyData last updated: 4/30/2026